- Procter & Gamble: FQ3 Non-GAAP EPS of $1.33beats by $0.04.
- Revenue of $19.4B (+7.1% Y/Y)beats by $710M.
- Shares+1.62% PM.
- The company raised its outlook for FY2022 all-in sales growth from a range of 3% to 4% to a range of 4% to 5% Y/Y vs. consensus growth of 4.2%; Organic sales growth from a range of 4% to 5% to a range of 6% to 7%.
- The company continues to expect core earnings per share growth for FY2022 in the range of 3% to 6% Y/Y vs. consensus growth of 3.5%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments